Drugs / intravenous immunoglobulin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01306578 Comparator | Jan 2007 → Dec 2009 | Guillain-Barre syndrome | Mansoura University Children Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | intravenous immunoglobulin | “intravenous immunoglobulin (IVIG) and plasma exchange (PE) treatment” PMID 21745374 ↗ Jul 2011 |
| Known as | IVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01306578 ↗ |
| Route | Intravenous | “intravenous immunoglobulin (IVIG)” NCT01306578 ↗ |